Cargando…
Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?
This letter reflects on the PALOMA‐3 study, as related to the safety analysis of premenopausal breast cancer patients.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469593/ https://www.ncbi.nlm.nih.gov/pubmed/28611237 http://dx.doi.org/10.1634/theoncologist.2016-0446 |
_version_ | 1783243606239215616 |
---|---|
author | Altundag, Kadri |
author_facet | Altundag, Kadri |
author_sort | Altundag, Kadri |
collection | PubMed |
description | This letter reflects on the PALOMA‐3 study, as related to the safety analysis of premenopausal breast cancer patients. |
format | Online Article Text |
id | pubmed-5469593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | AlphaMed Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-54695932017-07-13 Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning? Altundag, Kadri Oncologist Letters to the Editor This letter reflects on the PALOMA‐3 study, as related to the safety analysis of premenopausal breast cancer patients. AlphaMed Press 2017-06-12 2017-06 /pmc/articles/PMC5469593/ /pubmed/28611237 http://dx.doi.org/10.1634/theoncologist.2016-0446 Text en © AlphaMed Press 2017 |
spellingShingle | Letters to the Editor Altundag, Kadri Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning? |
title | Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning? |
title_full | Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning? |
title_fullStr | Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning? |
title_full_unstemmed | Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning? |
title_short | Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning? |
title_sort | safety analysis of premenopausal breast cancer patients in paloma‐3 study: is it worth mentioning? |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469593/ https://www.ncbi.nlm.nih.gov/pubmed/28611237 http://dx.doi.org/10.1634/theoncologist.2016-0446 |
work_keys_str_mv | AT altundagkadri safetyanalysisofpremenopausalbreastcancerpatientsinpaloma3studyisitworthmentioning |